Patents by Inventor Xiaozhen KANG

Xiaozhen KANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polypeptide carrier for presenting target polypeptide and uses thereof
    Patent number: 10987418
    Abstract: The invention relates to a polypeptide carrier for presenting a target polypeptide, and use thereof. In particular, the invention relates to a nucleic acid molecule, comprising a nucleotide sequence encoding a polypeptide carrier, and being used for insertion of a nucleotide sequence encoding a target polypeptide. In addition, the invention further relates to a recombinant protein comprising the polypeptide carrier and a target polypeptide. Furthermore, the invention further relates to use of the nucleic acid molecule and the recombinant protein. In addition, the invention further relates to a vaccine or a pharmaceutical composition useful for preventing, alleviating or treating HBV infection or a disease associated with HBV infection (e.g., hepatitis B), comprising a recombinant protein comprising the polypeptide carrier of the invention and an epitope from HBV.
    Type: Grant
    Filed: February 5, 2018
    Date of Patent: April 27, 2021
    Assignees: XIAMEN UNIVERSITY, YANG SHENG TANG COMPANY, LTD.
    Inventors: Tianying Zhang, Quan Yuan, Xueran Guo, Minxi Wei, Xiaozhen Kang, Jun Zhang, Ningshao Xia
  • POLYPEPTIDE CARRIER FOR PRESENTING TARGET POLYPEPTIDE AND USES THEREOF
    Publication number: 20200147205
    Abstract: The invention relates to a polypeptide carrier for presenting a target polypeptide, and use thereof. In particular, the invention relates to a nucleic acid molecule, comprising a nucleotide sequence encoding a polypeptide carrier, and being used for insertion of a nucleotide sequence encoding a target polypeptide. In addition, the invention further relates to a recombinant protein comprising the polypeptide carrier and a target polypeptide. Furthermore, the invention further relates to use of the nucleic acid molecule and the recombinant protein. In addition, the invention further relates to a vaccine or a pharmaceutical composition useful for preventing, alleviating or treating HBV infection or a disease associated with HBV infection (e.g., hepatitis B), comprising a recombinant protein comprising the polypeptide carrier of the invention and an epitope from HBV.
    Type: Application
    Filed: February 5, 2018
    Publication date: May 14, 2020
    Applicants: XIAMEN UNIVERSITY, YANG SHENG TANG COMPANY, LTD.
    Inventors: Tianying ZHANG, Quan YUAN, Xueran GUO, Minxi WEI, Xiaozhen KANG, Jun ZHANG, Ningshao XIA